AmInvest Research retains Buy on IHH with FV of RM6.25


KUALA LUMPUR: AmInvestment Research is maintaining its Buy call on IHH Healthcare with an unchanged fair value of RM6.25 a share.

It said on Friday its valuation was based on discounted cashflow with a weighted average cost of capital of 7%.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Powering on data centres
Medical insurance premiums on the rise
Kelington to reap the benefits of a diversified business strategy
Rising data centre ability
Making scents of success
Investors brace for 5% Treasury yields
Are there too many GPs and is the healthcare system overwhelmed?
Sapura Energy takes a step to turn the tide
Japan frets over relentless yen slide as BoJ keeps ultra-low rates
Singapore’s growth trajectory remains intact

Others Also Read